Program Head, Gastrointestinal Oncology

Fred Hutchinson Cancer Center:
Clinical Research Division Location

Seattle, WA

May 26, 2026

Associate Professor or Full Professor, Clinician-Scholar, Gastrointestinal Oncology

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications for the Program Head of Gastrointestinal (GI) Oncology. The position will be dual appointed with a primary faculty appointment in the Clinical Research Division at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology. The position will report to the Senior Vice President (SVP) of the Clinical Research Division at Fred Hutch and the Division Head of Hematology and Oncology at the UW.

We are seeking a highly motivated, visionary and accomplished scientific and clinical leader to head the GI Oncology Program at the Fred Hutch Cancer Center. The Program Head will oversee and strategically guide the GI Oncology Program, ensuring alignment with the institution's mission and goals. They will develop and implement a comprehensive vision and strategy for the GI Oncology Program, integrating basic, translational and clinical research with clinical care, while promoting education and mentorship.

The incumbent will lead and/or support groundbreaking research initiatives in gastrointestinal cancer, including preclinical studies, clinical trials, and translational research and will foster collaborations with bench researchers, translational researchers and clinical investigators at UW and Fred Hutch. The incumbent will serve as an academic, clinical and educational leader charged with organizing, directing and expanding the research efforts for an established team of clinical researchers involved in conducting clinical research and clinical trials in gastrointestinal cancer.

Responsibilities include assisting with faculty recruitment as well as oversight and mentorship of faculty, promotion of professional development for team members and representation of the GI Oncology Program at national and international conferences, workshops, and symposia. The incumbent will build and maintain strong relationships with external stakeholders, including industry partners, regulatory agencies, and funding organizations.

Competitive candidates will have an international reputation of leadership in both gastrointestinal cancer research and clinical excellence. They will have a long-standing track record of substantial basic, translational and/or clinical research with consistent primary author high-impact publications and/or grant funding.

Academic appointment at the University of Washington will be commensurate with experience, qualifications, and academic rank. University of Washington associate and full professors WOT hold indefinite appointments that align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.

The successful candidate will be appointed in the Clinician-Scholar track and will spend approximately 30% of time on clinical care. The remainder of the incumbent’s time will be protected for research, administrative oversight of the Fred Hutch/UW GI Oncology program, teaching and mentorship.

Faculty are expected to perform their primary activities on-site at Fred Hutch.

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.

With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five…